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Abstract— Reinforcement learning algorithms are gaining
popularity in fields in which optimal scheduling is important,
and oncology is not an exception. The complex and uncertain
dynamics of cancer limit the performance of traditional model-
based scheduling strategies like Optimal Control. Motivated by
the recent success of model-free Deep Reinforcement Learning
(DRL) in challenging control tasks and in the design of medical
treatments, we use Deep Q-Network (DQN) and Deep Determin-
istic Policy Gradient (DDPG) to design a personalized cancer
chemotherapy schedule. We show that both of them succeed in
the task and outperform the Optimal Control solution in the
presence of uncertainty. Furthermore, we show that DDPG can
exterminate cancer more efficiently than DQN presumably due
to its continuous action space. Finally, we provide some insight
regarding the amount of samples required for the training.
I. INTRODUCTION AND OBJECTIVES
Cancer is a common name that is given to a group of
diseases that involve the repeated and uncontrolled division
and spreading of abnormal cells. These abnormal tissues are
called tumors [1]. Early diagnosis and effective treatment
improve the survival rate of these diseases.
The optimal treatment schedule and drug dose vary
according to the stage of the tumor, the weight of the
patient, the white blood cell levels (immune cells),
concurrent illness and age of the patient. Thus, proper
scheduling and personalization of the chemotherapy
treatment are vital to reducing the mortality rate. This
motivated the use of techniques originating in engineering
fields – such as optimal control – to derive optimal drug
dosing for cancer chemotherapy [2]. A review of model-
based scheduling strategies is provided in [3].
One of the main challenges associated with the study
of cancer as a dynamical system is that it is known to
be complex, nonlinear, and its mechanisms of action are
uncertain. Consequently, first principle mathematical models
may not be able to account for all the variations in the
patient dynamics [1].
Motivated by the challenging nature of generating
accurate models of cancer dynamics and the recent success
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Fig. 1: Immune cells (in orange) attached to a tumour cell (brown).
This image was captured by a scanning electron microscope [4].
stories of using RL for control [5], [6], we use model-free
Deep-Reinforcement Learning (DRL) algorithms to design
a personalized cancer chemotherapy schedule. Particularly,
we will use Deep Q-Network (DQN) [7] (with a discrete
action space) and Deep Deterministic Policy Gradient [8]
(with continuous action space), and provide a comparison
of their performance.
RL and DRL have been successfully applied in different
medical treatment designs. For instance, in [9] DRL was
used to determine the optimal treatment regimes from
medical data. [10] developed automated radiation adaptation
protocols for Lung Cancer using DDPG. In [1], Q-learning
was used to design a chemotherapy schedule with a discrete
action space, and in [11] DL was used for the detection
of metastatic breast cancer. Moreover, [12] used DDPG to
control the drug dosing for suppressing cell growth modeled
through a stochastic logistic growth model.
The aim of this work is to develop in-silico trials to
compare the performance of model-based and model-free
techniques in scheduling a personalized chemotherapy
treatment. Particularly, our objectives include:
1) Scheduling the personalized chemotherapy treatment
by solving the optimal control problem to establish a
baseline for comparison and evaluate whether DQN
and DDPG provide similar performance.
2) Gaining a qualitative understanding of the amount of
training data (episodes) required by DQN and DDPG
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to perform similarly to the baseline policy.
3) Evaluating the robustness of the optimal controller,
DQN and DDPG policies in the presence of differ-
ent types of relevant uncertainties: parametric in the
dynamics, parametric in the initial conditions of the
model (diagnosis) and in the presence of a stochastic
forcing term in the tumor cell population dynamics.
4) Comparing the performance of DQN and DDPG in the
scenarios described above.
II. MODEL
In order to compute the optimal control policy and
the reward in DRL, a mathematical model that captures
the distribution and effects of the chemotherapy drug is
required. A realistic model should address tumor growth, the
reaction of the human immune system to the tumor growth,
and the effects of chemotherapy treatment on immune cells,
normal cells and tumor growth [2], [3].
We will simulate patient’s response to the treatment
through a pharmacological model of cancer chemotherapy,
given by a nonlinear and coupled system of 4 deterministic
Ordinary Differential Equations (ODEs) [1]:
N˙(t) = r2N(t)(1− b2N(t))− c4N(t)T (t)− a3N(t)C(t)
T˙ (t) = r1T (t)(1− b1T (t))− c2I(t)T (t)− c3T (t)N(t)− a2T (t)C(t)
I˙(t) = s+
ρI(t)T (t)
α+ T (t)
− c1I(t)T (t)− d1I(t)− a1I(t)C(t)
C˙(t) = −d2C(t) + u(t)
with N(0) = N0, T (0) = T0, I(0) = I0, C(0) = C0 and t ≥ 0
(1)
where I(t) is the number of immune cells, N(t) is the
number of normal cells, T (t) is the number of tumor cells
and C(t) is the drug concentration. The action or control is
the chemotherapy drug infusion rate u(t) [mg · l−1 · day−1],
which we will schedule through Optimal Control and DRL,
respectively. The initial conditions, N0, T0, I0 and C0 are
determined according to the diagnosis. From now on, we
will refer to this nonlinear model by x˙ = f(x, t), where
x˙ := dx/dt and x(t) := [N(t) T (t) I(t) C(t)]T. For the
sake of visualization, an electron micrograph of immune
and cancer cells is shown in Figure 1.
The model parameters and the corresponding values
used in our simulations are provided in Table I. Note that
the patient and his diagnosis determine both the initial
conditions and the value of the model parameters.
As mentioned in the Introduction, in order to test the
robustness of the optimal control and DRL policies, we
simulated the previously presented system of ODEs with
parametric uncertainty and also with a stochastic forcing
term. The reader is referred to the next Section for further
details on the uncertain scenarios considered.
III. SCENARIOS CONSIDERED
A personalized scheduling of chemotherapy treatment
is fundamental to patient’s recovery from the disease.
When designing the treatment schedule, it is important to
optimize the amount of drug used in order to regulate the
potentially lethal side effects of chemotherapy, since often
the patient’s immune system weakens and becomes prone
to life-threatening infections, diminishing its capability to
eradicate cancer [1].
Consequently, we obtained the Optimal Control and DRL
policies for two different cases: a preliminary and somewhat
unrealistic Case 0, in which the goal is to exterminate cancer
regardless of the state of the rest of the cell populations.
We used this case to validate our algorithms, codes and
parameter and hypermarameter values. Then, we simulated a
Case Patient, in which cancer is eradicated while preserving
a minimum population of normal and immune cells in
order to guarantee patient’s safety. In both cases, the initial
condition was the same: [1 0.7 1 0]T.
A. Case 0
The optimal control problem for Case 0 is formulated
through the following nonlinear program:
min
u,tf
∫ tf
0
T (τ) dτ
s. t.
x˙ = f(x, u)
x(0) =
[
1 0.7 1 0
]T
0 ≤ u ≤ 10 mg/(day l)
T (tf ) = 0
(2)
Both the policy u(t) and the length of the treatment tf are
determined by the optimal solution. The hard constraints
correspond to the dynamics of cancer and the initial state of
the patient, bounds in the drug-rate and the target of cancer
eradication. The cost is the area enclosed by the tumor cell
population (note that T (t) is nonnegative) and the time axis,
between t = 0 and t = tf . For the DRL algorithms, the
reward used is R = −dt · T , where dt corresponds to the
length of the timestep, and it is a fixed value. Note that
dt is included in the reward just to make the comparison
with the cost functional used in the Optimal Control program
straightforward.
B. Case Patient
In order to guarantee patient’s safety during the treatment,
additional state constraints are added to the program (2).
Particularly, the program is augmented with the constraints
N(t) ≥ 0.4 and I(t) ≥ 0.4.
In the case of the DRL algorithms, the constraints are
imposed softly by modifying the reward function:
R = dt · (−T − 0.5 · [N < 0.4]− 0.5 · [I < 0.4]) (3)
TABLE I: Parameters of the model, description and the values used in our optimal control policy computation and training of DRL
algorithms unless otherwise indicated. Extracted from [1].
where [·] denotes the Iverson bracket. The last two terms
of equation (3) penalize the violation of the constraints
N(t) ≥ 0.4 and I(t) ≥ 0.4. Note that, for the cases in
which the soft constraints are satisfied, this reward is the
negative of the Riemann sum approximation of the area
below the curve of the number of tumor cells T (i.e. it is
a rectangular approximation to the negative of the integral
cost used in the optimal control problem).
Furthermore, in order to test the robustness of the
obtained policies, different types of relevant sources of
uncertainty will be considered regarding the diagnosis,
growth-rate and dynamics of the tumor. The corresponding
results are provided in Section VI.
1) Parametric uncertainty: model parameter
The per-unit growth-rate of the tumor, r1, represents how
aggressive the disease is. Thus, an accurate estimation of
its value is important for the computation of the optimal
control policy. We systematically varied its value and
obtained the range for which the optimal control problem
is feasible, as well as the sensitivity of the nominal optimal
control policy to perturbations in the value of this parameter.
2) Parametric uncertainty: initial condition
A wrong estimation of the initial size of the tumor T0,
will also have an impact on the performance of the optimal
policy. We will systematically evaluate the robustness of the
nominal policy to perturbations on T0.
3) Stochastic forcing in tumor dynamics
We simulated a system of SDEs of the form:
dxt = f(xt, t)dt+G(xt, t)dWt (4)
where the first term is the drift and corresponds to the
deterministic dynamics given by the ODEs, and the second
one is the diffusion term, modeled by a constant G in our
case and applied only to the equation that gives the evolution
of the population of tumor cells T (t). Wt denotes a Wiener
process, common in the motion of cells. We simulated the
SDEs using the Euler-Maruyama scheme.
IV. METHODS AND ALGORITHMS
A. Optimal Control
The general form of a finite-horizon optimal control prob-
lem in Bolza form is:
max
u∈U,T
J =
∫ T
0
F (x(t),u(t), t) dt+ S(x(T ), T )
s. t.
x˙ = f(x(t),u(t))
x(0) = x0
g(x(t),u(t), t) ≥ 0
h(x(t), t) ≥ 0
a(x(T ), T ) ≥ 0
b(x(T ), T ) = 0
(5)
Inspection of the program (2) reveals that it constitutes
a particular case of problem (5) and thus can be solved
using standard optimal control techniques. Something to
note is that the control solution provided by (5) will usually
be open-loop (i.e. the control policy will be a function of
time, as opposed to feedback or closed-loop control laws, in
which the control is a function of the state. Usually this last
case is more desirable since it accounts for discrepancies
between the real dynamics and the predictions made by the
model and corrects the control input accordingly, making
the controller more robust to uncertainty).
B. Deep Reinforcement Learning
DDPG and DQN algorithms are considered. Both DDPG
and DQN share two common features: they are off-policy
and model-free algorithms. Off-policy means that the
behaviour policy used is not the same as the policy being
improved. This allows the use of a memory replay, and the
use of any exploration strategy. Model-free means that the
algorithm does not try to estimate the transition matrix of
the dynamics of the environment T (st+1|st, at). Instead, it
estimates the optimal policy or value function directly.
The differences between these two algorithms are
highlighted below.
1) Deep Q Network (DQN)
Deep Q Network was proposed in [7], and the main
difference with respect to standard Q-learning is the use of
a neural network to approximate the action-value function
Q(s, a). The DQN algorithm is shown in Alg. 1 (taken
from [7]).
The inclusion of a neural network, usually leads to an
unstable training due to two factors: the correlation between
samples and the non-stationary targets. These two challenges
are addressed by DQN using [13]:
• An experience replay: In a replay buffer, a dataset of
tuples (si, ai, ri, st+1) are saved. During the training,
the agent will randomly sample mini-batch samples
from this replay buffer (line 12 of the algorithm).
This allows a stabilization of the training process, and
a better approximation to i.i.d samples removing the
correlation between them.
• Fixed Q-targets: During several updates, the target
network weights used in the target calculation are fixed
(lines 2, 3, 16).
DQN is mainly used for problems with a discrete
action space. However, some applications make use of the
Normalized Advantage Function (NAF) to apply DQN in
continuous action spaces [14].
2) Deep Deterministic Policy Gradient (DDPG))
DDPG was proposed in [8]. The algorithm used by DDPG
is shown in Alg. 2 (taken from [8]), and its main character-
istics are these ones [8], [15], [16]:
• Policy-gradient: DDPG tries to estimate the gradient
of the expected return, and the policy is updated using
this estimate.
• Actor-critic: DDPG has two different structures (see
also Fig. 2) :
– Actor: The actor contains the policy function. It
takes the state of the environment as input, and
produces an action.
– Critic: From the state of the environment and the
reward received by the action taken by the actor,
the critic produces the temporal difference error.
This error is used to update both the actor (line
14) and the critic (line 13).
Both the actor and critic described above are represented
using neural networks.
V. IMPLEMENTATION
A. Optimal Control
We solved the optimal control problem using direct
collocation methods [17], which transcribe the continuous
Fig. 2: Actor and Critic used in DDPG. Adapted from [15].
Algorithm 1: DQN
1 Initialize replay memory D to capacity N
2 Initialize action-value function Q with random weights θ
3 Initialize target action-value function Qˆ with random weights
4 θ− = θ
5 for episode=1 :M do
6 Initialize sequence s1 = {x1} and preprocessed sequence
φ1 = φ(s1)
7 for t=1 : T do
8 With probability  select a random action at
9 otherwise select at = argmaxaQ (φ (st) , a; θ)
10 Execute action at in emulator and observe reward rt and
image xt+1
11 Set st+1 = st, at, xt+1 and preprocess φt+1 = φ (st+1)
12 Store transition (φt, at, rt, φt+1) in D
13 Sample random minibatch of transitions (φj , aj , rj , φj+1)
from D
14 Set yj ={
rj if episode terminates at step j + 1
rj + γmaxa′ Qˆ
(
φj+1, a
′; θ−
)
otherwise
15 Perform a gradient descent step on (yj −Q (φj , aj ; θ))2
with respect to the network parameters θ
16 Every C steps reset Qˆ = Q
dynamics and control functions to a finite set of algebraic
variables and then solve a high-dimensional non-linear
program (NLP). We used the MATLAB implementation of
ICLOCS2 [18], the open-source Imperial College London
Optimal Control software (available for download here)
in conjunction with the open-source NLP solver IPOPT
[19]. We modified the open-source code and introduced the
dynamics of cancer (the ODE system), cost functional and
constrains, as well as the desired options and tolerances for
the solvers.
We used h-methods for the transcription, particularly the
Hermite-Simpson method with automatic mesh refinement
and an initial number of 200 nodes. Regarding numerical
tolerances, we allowed errors of up to 10−2 in the state
and control bounds, and in the terminal condition of cancer
eradication. The optimal control solution for both the Case
0 and Case Patient is provided in Section VI.
Algorithm 2: DDPG
1 Initialize critic network Q(s, a|θQ) and actor µ(s|θµ) with weights
θQ and θµ.
2 Initialize target network Q′ and µ′ with weights θQ
′ ← θQ,
θµ
′ ← θµ
3 Initialize replay buffer R
4 for episode=1 :M do
5 Initialize a random process N for active exploration
6 Receive initial observation state s1
7 for t = 1 : T do
8 Select action at = µ(st|θµ) +Nt according to the current
policy and exploration noise
9 Execute action at and observe reward rt and new state st+1
10 Store transition (st, at, rt, st+1) in R
11 Sample a random minibatch of N transitions
(si, ai, ri, si+1) from R
12 Set yi = ri + γQ′(si+1, µ′(si+1|θµ′ )|θQ′ )
13 Update critic by minimizing the loss:
L = 1
N
∑
i
(
yi −Q
(
si, ai|θQ
))2
14 Update the actor policy using the sampled policy gradient:
∇θµJ ≈
1
N
∑
i∇aQ (s, a|θQ)
∣∣
s=si,a=µ(si)
∇θµµ (s|θµ)|si
15 Update the target networks:
16
θQ
′ ← τθQ + (1− τ)θQ′
θµ
′ ← τθµ + (1− τ)θµ′
TABLE II: Parameters used in DQN and DDPG
Parameter DQN DDPG
Replay Start Size 103 5 · 103
Layers 2 3
Hidden Units per layer 100 300
Discount Factor γ 0.99 0.995
B. Reinforcement Learning
To implement the DRL algorithms, we used the open-
source library ChainerRL [20]. Moreover, we created an
environment using the OpenAI Gym [21] framework. This
environment takes an action and the current state, and
returns the next observation and the reward obtained. In
this environment, we implemented the system of ODEs, and
solved it using the numerical integration methods provided
by Scipy [22].
The values of the most relevant parameters of the DQN
and DDPG implementations are shown in Table II. Note
that we used γ ≈ 1 to match the reward used in Optimal
Control as well as possible.
To improve the convergence and the training times, all
the states, actions and the reward were normalized to values
in [0, 1], and CuPy was used.
Note that both in DDPG and DQN, it is required to select
the size of the time steps taken by the agent during an
episode. We used a time step size of 0.3 days, which achieved
a reasonable training time.
VI. RESULTS
A. Case 0
The results for the preliminary Case 0 (in which there are
not constraints on N(t) and I(t)) are shown in Fig. 3. Note
that the policy found by all the algorithms (O.C., DDPG
and DQN) is the same: apply the maximum allowed drug
infusion rate until the cancer is exterminated, which is the
expected solution.
0
5
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0
5
10
uOC(t)
0 5 10
t [days]
uDQN  (t)
uDDPG    (t)
(a)
(b)
(c)
(d)
Fig. 3: Results for the preliminary Case 0. (a) Trajectories of the
states when the optimal drug-rate is applied. Policies provided by
(b) O.C. (c) DQN (d) DDPG. Note that (b)-(d) match. The shaded
regions represent the feasible control region.
B. Case Patient
In this case, we add the constraints N(t) ≥ 0.4 and
I(t) ≥ 0.4 to the program. The optimal policies found
by the three algorithms for the nominal growth tumor rate
(r1 = 1.5) are shown in Fig. 5. All the policies are able
to exterminate the cancer in ∼ 15 days. Note also that
the policies u(t) provided by the different algorithms share
some resemblances: Maximum allowed drug infusion at the
beginning of the treatment, followed by an average value
∼ 2.5mg · l−1 · day−1. In this case, the cost of the solutions
provided by DDPG and DQN is slightly higher than that of
O.C.
The convergence rates for DDPG and DQN are shown
in Fig. 6. The training was stopped when the average of
the Q-value reached a stationary behaviour. The training
for each case considered took ∼ 20 minutes. We also
note that the shape of the average Q (see Figure 6) is that
expected from a successful training procedure (see [23]
for example): After the replay buffer has been filled, the
average Q increases at the beginning of the training, it
reaches a maximum (where the agent overestimates the Q
value), and then decreases to achieve a stationary value.
1) Parametric uncertainty: Model Parameter
To evaluate the sensitivity of the optimal policy to
changes in r1, we perturbed r1 around its nominal value
and obtained the range for which an optimal policy exists.
t [days] t [days] t [days]
OPTIMAL CONTROL DQN10 DDPG
r1=1.3 r1=1.3 r1=1.3
r1=1.4 r1=1.4 r1=1.4
r1=1.5 r1=1.5 r1=1.5
r1=1.6 r1=1.6 r1=1.6
r1=1.7 r1=1.7 r1=1.7
u 
[m
g/
l d
ay
]
Fig. 4: Optimal policies provided by the different methods when sweeping the values of r1.
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Fig. 5: Results for the Case Patient. (a) O.C. (b) DQN (c) DDPG.
Row 1 provides the policies and row 2 the state evolution when the
corresponding policy is applied. The shaded regions represent the
feasible control region.
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Fig. 6: Convergence rates in both DQN10 and DDPG. For DDPG,
both the Critic and Actor losses are shown. The values of these
plots are normalized.
The problem is feasible for values r1 ≤ 1.7 and the
corresponding policies are plotted in Fig. 4. Again, DDPG
and DQN obtain a similar policy to that provided by O.C.,
although some of them present an oscillatory behaviour.
Both for DQN and DDPG, these oscillations may be due
to the length of the time step (0.3 days), and might be
reduced by refining it. Moreover, for the case of DQN the
coarse discretization (10 nodes) of the action space should
be accounted for.
Once we obtained the values of r1 for which the problem
is feasible, we tested the optimal policy obtained for
r1 = 1.5 in different scenarios, where r1 6= 1.5. The results
are shown in Fig. 7. In all the algorithms, the policy found
eradicates the cancer for r1 ≤ 1.5, and does not cure it for
r1 ≥ 1.6. However, for the case r1 = 1.55, DRL algorithms
are successful exterminating the cancer, but O.C. is not.
The increased robustness of DRL to parametric uncertainty
might be due to its exploration phase: exploration makes the
policies found by DRL algorithms contain more information
than the optimal control solution, which only focuses on
finding a minimum for the given model.
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Fig. 7: Test of the performance of the nominal policies (com-
puted/trained with r1 = 1.5) to perturbations in the value of r1.
(a) O.C. (b) DQN10 (c) DDPG. DRL methods show improved
robustness to perturbations than O.C.
2) Parametric uncertainty: initial condition
For this case, the agent is trained with the nominal initial
condition T0 = 0.7, and tested with perturbed values of
T0. The perturbed values and corresponding results are
shown in Fig. 8. Note that DRL is able to exterminate
the cancer for all the cases, while O.C. fails to do it for
T0 ≥ 3.5. Again, this argues for the increased robustness of
the policies provided by DRL in comparison to O.C.
TO
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(t)
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t [days]
(a)
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(c)
Fig. 8: Evolution of the tumor cell population when the policy
obtained for the nominal initial condition (computed/trained with
T0 = 0.7) is applied for perturbed initial size of the tumor. (a) O.C.
(b) DQN10 (c) DDPG. It is remarkable that while optimal control
does not manage to exterminate the disease in all the cases, DRL
methods do, showing increased robustness. The first 5 days have
been removed from the graph for the sake of visualization.
3) Stochastic forcing in tumor dynamics
In this last scenario, the agent is tested with a stochastic
forcing term in the dynamics of T (t). The plots of the
mean and standard deviations of the solutions found
are shown in Fig. 9. DQN and DDPG drive the tumor
closer to extermination than O.C. at the end of the treatment.
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Fig. 9: Evolution of T (t) for the noisy case. Note the improved
performance of DDPG and DQN at t = tf .
C. Sampling
An interesting question to investigate is the dependence of
learning in DQN and DDPG on the number of episodes. This
question is specially relevant in data-poor scenarios, where
one may wonder if the size of the dataset is enough to obtain
a suitable policy. With this aim, the agent was evaluated after
each training episode, and its cost was compared with that
of O.C. In the case of DQN, seven different discretizations
6
4
Fig. 10: Mean cost (-reward) of the policies found as a function
of the training episodes for each algorithm compared to that of
the optimal controller. Legend indicates the algorithms with the
respective training episodes.
of the action space were considered: 7, 10, 20, 30, 40, 50
and 60 nodes. The resulting plot is shown in Fig. 10. It is
observed that the DRL costs asymptote to the optimal one
and that, after ∼ 1500 episodes, DDPG obtains a cost that is
close to that of Optimal Control. Note also that, in general,
DDPG tends to obtain better agents than DQN.
VII. CONCLUSIONS AND FUTURE WORK
This work presented a comparison between classical
O.C. and model-free DRL approaches, both in discrete and
continuous action space. We showed that, with an accurate
model of the dynamics, O.C. provides the best solution,
but closely followed by DRL. Moreover, we showed that
in the presence of parametric or stochastic uncertainty,
DRL approaches have the potential to outperform classical
trajectory optimization O.C. techniques.
In the Case 0, all the algorithms found the same optimal
policy. In the Case Patient, the policies found by DRL
perform similarly to O.C, but they exhibit increased
robustness to uncertainties. Regarding the relative merits of
DQN and DDPG, we found that DDPG outperforms DQN,
presumably due to its continuous action space. Furthermore,
it seems to learn faster.
The sampling analysis of the algorithms showed that
approximately 1500 calls to the model are needed for DDPG
to obtain a performance close to optimal.
As future work, we consider comparing the perfomance
of DDPG and DQN with robust optimal control, where
uncertainty on the dynamics is taken into account in the
formulation of the optimal control program at the expense of
increasing the cost associated to the policy found. Moreover,
we plan also to compare the performace of DDPG and DQN
with Model Predictive Control, that benefits from feedback
in each iteration.
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